Making the Best Match: Selecting Outcome Measures for Clinical Trials and Outcome Studies

被引:123
|
作者
Coster, Wendy J. [1 ]
机构
[1] Boston Univ, Coll Hlth & Rehabil Sci, Sargent Coll, Dept Occupat Therapy, Boston, MA 02215 USA
来源
关键词
clinical trials as topic; decision making; guidelines as topic; outcome assessment (health care); treatment outcome; INPATIENT REHABILITATION; DISABILITY; STROKE; RESPONSIVENESS; RECOVERY; DESIGN; HEALTH;
D O I
10.5014/ajot.2013.006015
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Selecting an appropriate outcome measure is a critical step in designing valid and useful clinical trials and outcome studies. This selection process needs to extend beyond examining basic psychometric properties to consider additional features of instruments that may affect their validity and utility for the study's purpose. This article discusses these additional factors and their potential impact on outcome measurement. Guidelines are proposed to help clinical researchers and consumers of clinical research literature evaluate the match between the study purpose, population, and instrument. Coster, W. J. (2013). Making the best match: Selecting outcome measures for clinical trials and outcome studies. American Journal of Occupational Therapy, 67, 162-170. http://dx.doi.org/10.5014/ajot.2013.006015
引用
收藏
页码:162 / 170
页数:9
相关论文
共 50 条
  • [1] SELECTING APPROPRIATE OUTCOME MEASURES FOR ALS CLINICAL TRIALS
    Arjunji, R.
    Glowienka, E.
    Maru, B.
    Wiesner, T.
    Meriggioli, M.
    Dabbous, O.
    [J]. VALUE IN HEALTH, 2019, 22 : S739 - S739
  • [2] WHICH OUTCOME MEASURES ARE THE BEST FOR CLINICAL TRIALS IN EPIDERMOLYSIS BULLOSA?
    Rogers, Clare L.
    Gibson, Matthew
    Kern, Johannes S.
    Martin, Linda
    Robertson, Susan
    Daniel, Benjamin S.
    Su, John C.
    Murrell, Dedee F.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 38 - 39
  • [3] Which outcome measures are the best for clinical trials in Epidermolysis Bullosa?
    Rogers, C. L.
    Gibson, M.
    Kern, J. S.
    Martin, L.
    Robertson, S.
    Daniel, B. S.
    Su, J. C.
    Murrell, D. F.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 110 - 111
  • [4] Outcome measures in clinical trials
    Heyse, JF
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2004, 13 (02) : 87 - 87
  • [5] Which outcome measures in SLE clinical trials best reflect medical judgment?
    Thanou, Aikaterini
    Chakravarty, Eliza
    James, Judith A.
    Merrill, Joan T.
    [J]. LUPUS SCIENCE & MEDICINE, 2014, 1 (01):
  • [6] Considerations and Challenges in Selecting Patient-Reported Outcome Measures for Clinical Trials in Nephrology
    Ju, Angela
    Tong, Allison
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (11): : 1882 - 1884
  • [7] Outcome Measures for Clinical Trials in Down Syndrome
    Esbensen, Anna J.
    Hooper, Stephen R.
    Fidler, Deborah
    Hartley, Sigan L.
    Edgin, Jamie
    d'Ardhuy, Xavier Liogier
    Capone, George
    Conners, Frances A.
    Mervis, Carolyn B.
    Abbeduto, Leonard
    Rafii, Michael
    Krinsky-McHale, Sharon J.
    Urv, Tiina
    [J]. AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2017, 122 (03): : 247 - 281
  • [8] Outcome measures in multiple sclerosis clinical trials
    Andersson, PB
    Goodkin, DE
    [J]. BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 409 - 428
  • [9] OUTCOME MEASURES FOR CLINICAL-TRIALS IN RHEUMATOLOGY
    TUGWELL, P
    BUCHANAN, W
    BOMBARDIER, C
    [J]. EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION, 1983, 6 (02) : 140 - 141
  • [10] Outcome Measures in Clinical Trials for Multiple Sclerosis
    Caspar E. P. van Munster
    Bernard M. J. Uitdehaag
    [J]. CNS Drugs, 2017, 31 : 217 - 236